DNA Damage Is a Potential Marker for TP53 Mutation in Colorectal Carcinogenesis

被引:0
|
作者
Scalise J.R. [1 ]
Poças R.C.G. [1 ]
Caneloi T.P. [2 ]
Lopes C.O. [2 ]
Kanno D.T. [2 ]
Marques M.G. [2 ]
Valdivia J.C.M. [2 ]
Maximo F.R. [2 ]
Pereira J.A. [3 ]
Ribeiro M.L. [1 ]
Priolli D.G. [1 ,4 ]
机构
[1] Postgraduate Programme Strictu Senso in Health Science, Sao Francisco University Medical School, Sao Paulo
[2] Scientific Initiation Student, Scientific Initiation Programme, Sao Francisco University Medical School, Sao Paulo
[3] Department of Pathology, Sao Francisco University Medical School, Sao Paulo
[4] Rua São Vicente 614. Jardim Paulista, Atibaia, CEP: 12947-390, SP
基金
巴西圣保罗研究基金会;
关键词
Adenocarcinoma; Adenoma; DNA damage; Immunohistochemistry; Tumor suppressor protein p53;
D O I
10.1007/s12029-016-9846-0
中图分类号
学科分类号
摘要
Purpose: The ability to measure oxidative DNA damage in a tissue allows establishment of the relationship between DNA damage and mutations in normal and neoplastic cells. It is well known that TP53 is a key inhibitor of tumor development and preserves the genome integrity in each cell. The aim of the present study was to investigate the relationship between DNA damage and TP53 mutation in colorectal adenoma and adenocarcinoma, and the value of DNA damage as potential marker of TP53 mutation in non-tumor tissues adjacent to colon malignant lesions. Methods: Tissue samples were obtained by colonoscopy from patients with adenoma and/or adenocarcinoma and from healthy volunteers. Diagnosis was defined by histopathology. Immunohistochemistry with computer-assisted image analysis was performed to quantify TP53 mutation. Oxidative DNA damage was determined by comet assay. Statistical analyses were performed with 5 % of significance level. Results: The TP53 level was higher in non-tumor tissues from tumor patients than in normal tissues from healthy volunteers (p = 0.01). Likewise, higher TP53 levels were observed in tumor tissues compared with the non-tumor tissues (p = 0.00). Oxidative DNA damage levels were higher in tumor tissues than in non-tumor tissues (p = 0.00). The amount of TP53 (p = 0.00) and oxidative DNA damage (p = 0.00) in normal and tumor tissue was related. The relationship between oxidative DNA damage and TP53 mutation was demonstrated in all samples (p = 0.00). Conclusion: Oxidative DNA damage is an intervening variable for TP53 mutation in colorectal adenoma-carcinoma. Our data suggests that oxidative DNA damage is a potential marker of TP53 mutation in colorectal carcinogenesis. © 2016, Springer Science+Business Media New York.
引用
收藏
页码:409 / 416
页数:7
相关论文
共 50 条
  • [1] TP53 MUTATION STATUS IS A POTENTIAL PREDICTIVE MARKER IN MEDULLOBLASTOMA
    Pfaff, Elke
    Remke, Marc
    Sturm, Dominik
    Witt, Hendrik
    von Bueren, Andre O.
    Wittmann, Andrea
    Schoettler, Anna
    Scheurlen, Wolfram
    Kulozik, Andreas E.
    Witt, Olaf
    von Deimling, Andreas
    Rutkowski, Stefan
    Hawkins, Cynthia
    Tabori, Uri
    Lichter, Peter
    Korshunov, Andrey
    Pfister, Stefan M.
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 799 - 799
  • [2] TP53 mutation in colorectal cancer
    Iacopetta, B
    HUMAN MUTATION, 2003, 21 (03) : 271 - 276
  • [3] Mutation and methylation analysis of TP53 in adrenal carcinogenesis
    Sidhu, S
    Martin, E
    Gicquel, C
    Melki, J
    Clark, SJ
    Campbell, P
    Magarey, CJ
    Schulte, KM
    Röher, HD
    Delbridge, L
    Robinson, BG
    EJSO, 2005, 31 (05): : 549 - 554
  • [4] Endogenous DNA damage and TP53 mutation profiles in human cancers
    Hainaut, P
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 153 - 154
  • [5] Is TP53 mutation status a predictive marker in medulloblastoma?
    Pfaff, E.
    Remke, M.
    Sturm, D.
    Witt, H.
    von Bueren, A. O.
    Wittmann, A.
    Schoettler, A.
    Scheurlen, W.
    Kulozik, A. E.
    Witt, O.
    von Deimling, A.
    Rutkowski, S.
    Hawkins, C.
    Tabori, U.
    Lichter, P.
    Korshunov, A.
    Pfister, S. M.
    KLINISCHE PADIATRIE, 2010, 222 (06): : 415 - 415
  • [6] TP53 and liver carcinogenesis
    Staib, F
    Hussain, SP
    Hofseth, LJ
    Wang, XW
    Harris, CC
    HUMAN MUTATION, 2003, 21 (03) : 201 - 216
  • [7] TP53 mutation in the colorectal adenoma-carcinoma sequence
    Hao, XP
    Frayling, I
    Du, MQ
    Peng, HZ
    Pan, LX
    Willcocks, T
    Talbot, IC
    JOURNAL OF PATHOLOGY, 1998, 184 : 3A - 3A
  • [8] The role of TP53 in cervical carcinogenesis
    Tommasino, M
    Accardi, R
    Caldeira, S
    Dong, W
    Malanchi, E
    Smet, A
    Zehbe, I
    HUMAN MUTATION, 2003, 21 (03) : 307 - 312
  • [9] Mutation and function of TP53
    Milner, J
    BRAIN PATHOLOGY, 2000, 10 (04) : 504 - 504
  • [10] The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
    Leroy, Bernard
    Fournier, Jean Louis
    Ishioka, Chikashi
    Monti, Paola
    Inga, Alberto
    Fronza, Gilberto
    Soussi, Thierry
    NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) : D962 - D969